An Underactive Thyroid Gland Causes

Hashimoto’s thyroiditis — also called Hashimoto’s disease or chronic lymphocytic thyroiditis — is an autoimmune condition in which the immune system mistakenly attacks the thyroid gland’s own cells. Over time, this immune assault causes progressive destruction of thyroid tissue, reducing the gland’s capacity to produce T4 and T3. The mechanism involves both antibody-mediated and cell-mediated immune responses: the body produces antithyroid peroxidase (anti-TPO) antibodies and antithyroglobulin antibodies that mark thyroid tissue for destruction.

What makes Hashimoto’s particularly important for assignments is that it develops slowly and insidiously. The remaining thyroid tissue initially compensates by working harder under TSH stimulation, which is why TSH rises before T4 falls. This phase — subclinical hypothyroidism — is detectable on blood tests but may produce no or minimal symptoms. Eventually the compensatory mechanism fails and overt hypothyroidism develops. For nursing and medical students writing case studies or care plans, this progression is clinically significant: early detection during the subclinical phase allows treatment before significant tissue damage accumulates.

Hashimoto’s is more common in women than men, with a roughly 7:1 female-to-male ratio. It has a strong genetic component — a family history of thyroid disease or other autoimmune conditions (type 1 diabetes, rheumatoid arthritis, lupus) significantly increases risk. For assignments asking about risk factors, these associations are worth including.

Radioactive iodine (RAI) treatment is commonly used for hyperthyroidism — Graves’ disease in particular — and for thyroid cancer. The iodine is absorbed by thyroid cells, which are then destroyed by the radiation. The intent is to reduce or eliminate hyperfunctioning thyroid tissue. The predictable consequence, particularly when high doses are used or when treatment is followed by thyroid cancer surveillance, is permanent hypothyroidism. Patients who receive RAI almost always require lifelong levothyroxine replacement therapy afterward.

Thyroid surgery — partial thyroidectomy or total thyroidectomy — produces the same result through mechanical removal of glandular tissue. If the entire gland is removed (for thyroid cancer or severe Graves’ disease), permanent hypothyroidism is inevitable. If only part of the gland is removed, the remaining tissue may maintain adequate hormone production — but not always, particularly if the underlying condition that prompted surgery also affects the remnant tissue. For pathophysiology assignments, this is a clean cause-effect relationship to demonstrate: less glandular tissue → less hormone production → hypothyroidism.

Several medications can cause or contribute to hypothyroidism, either by interfering with thyroid hormone synthesis, altering TSH signaling, or causing direct thyroid inflammation. This is a particularly important category for pharmacology students and nursing students managing patients on long-term medications.

• Lithium — used for bipolar disorder — inhibits thyroid hormone synthesis and secretion. Long-term lithium therapy is associated with clinical hypothyroidism in up to 20–40% of patients, and subclinical hypothyroidism in an even higher proportion. Any assignment involving psychiatric medication management should note thyroid function monitoring as a clinical requirement.
• Amiodarone — an antiarrhythmic drug — contains about 37% iodine by weight. High iodine load can inhibit thyroid hormone synthesis (the Wolff-Chaikoff effect). Amiodarone can cause both hypothyroidism and hyperthyroidism depending on the patient’s baseline thyroid function and the duration of treatment.
• Antithyroid drugs such as propylthiouracil (PTU) and carbimazole, used to treat hyperthyroidism, can produce iatrogenic hypothyroidism if the dose is excessive or treatment is not titrated carefully.
• Immune checkpoint inhibitors — newer cancer immunotherapies including pembrolizumab and nivolumab — can trigger autoimmune thyroiditis as an immune-related adverse effect. This is an increasingly important clinical category given the expanding use of immunotherapy in oncology.
• Interferon-alpha used in some viral hepatitis treatments, and tyrosine kinase inhibitors used in certain cancers, can also impair thyroid function through various mechanisms.

Iodine is an essential raw material for thyroid hormone synthesis. Both T4 (thyroxine — four iodine atoms) and T3 (triiodothyronine — three iodine atoms) literally require iodine in their molecular structure. Without enough dietary iodine, the thyroid cannot produce adequate amounts of either hormone regardless of how well the gland itself functions.

Iodine deficiency remains the leading cause of hypothyroidism and preventable intellectual disability worldwide, predominantly in developing regions of South Asia, sub-Saharan Africa, and parts of Latin America where iodized salt programs are incomplete or absent. In iodine-sufficient countries — where dietary iodine comes from iodized salt, dairy, seafood, and fortified foods — deficiency is rare. For global health, public health, or comparative international health assignments, iodine deficiency is a critically important cause. For assignments set in a U.S. or UK clinical context, it moves to the background, but it shouldn’t be omitted entirely.

The response to iodine deficiency includes compensatory thyroid enlargement — a goitre — as the gland attempts to produce more hormone by increasing its own mass. This goitre development is one of the most visible and historically documented signs of iodine deficiency at the population level.

Postpartum thyroiditis is an autoimmune inflammation of the thyroid gland occurring within the first year after delivery. The immune system, which is naturally suppressed during pregnancy to tolerate the fetus, rebounds after delivery — and in susceptible women (particularly those with pre-existing anti-TPO antibodies), this immune rebound triggers thyroid inflammation. The classic pattern involves an initial phase of hyperthyroidism lasting a few weeks as stored hormone leaks from the inflamed gland, followed by a hypothyroid phase as hormone stores are depleted and the damaged gland cannot produce adequate replacement. Most women recover normal thyroid function within 12–18 months, but a significant minority — roughly 20–40% — develop permanent hypothyroidism.

For maternal-child nursing or obstetric nursing assignments, postpartum thyroiditis has direct clinical relevance: its symptoms (fatigue, depression, weight changes, cognitive difficulties) overlap heavily with normal postpartum experience and with postpartum depression, making it easy to miss on clinical assessment if thyroid function testing is not included. This diagnostic overlap is worth addressing explicitly in any assignment that touches on postpartum care.

Radiation therapy targeting the head, neck, or upper chest — used for Hodgkin’s lymphoma, head and neck cancers, and certain brain tumors — can damage the thyroid gland if it lies within or near the radiation field. The risk is dose-dependent and time-dependent: higher cumulative doses and longer follow-up periods after treatment are associated with higher rates of hypothyroidism. In childhood cancer survivors who received head and neck radiation, hypothyroidism is one of the most common late effects, sometimes manifesting decades after treatment.

For oncology nursing or cancer survivorship assignments, this is clinically important: long-term thyroid function monitoring is a standard component of post-treatment surveillance for patients who received cervical, mediastinal, or cranial radiation. Assignments in this area should frame thyroid monitoring as a survivorship care planning issue, not just an acute treatment concern.

Congenital hypothyroidism affects roughly 1 in 2,000–4,000 newborns, making it one of the most common preventable causes of intellectual disability. Thyroid hormones are critical for brain development, myelination, and bone maturation during the fetal and neonatal period. An untreated neonate with hypothyroidism may initially appear normal — maternal thyroid hormones provide some protection in utero — but within weeks, growth and neurological development begin to diverge from normal. Classic signs in newborns include prolonged neonatal jaundice, poor feeding, hypotonia, constipation, large tongue, and a hoarse cry. Universal newborn screening via TSH measurement in a heel-prick blood sample — performed in the first 24–72 hours of life — enables early diagnosis and levothyroxine replacement, which when initiated within the first two weeks of life largely prevents neurological sequelae. This screening protocol is a key public health intervention that nursing students are expected to know.

Pregnancy increases thyroid hormone demand by approximately 40–50%, driven by rising human chorionic gonadotropin (hCG) levels, increased thyroxine-binding globulin production, and the metabolic demands of the growing fetus. Women with pre-existing subclinical or overt hypothyroidism require careful monitoring and often dose adjustment of levothyroxine during pregnancy. Untreated maternal hypothyroidism is associated with increased risk of miscarriage, preterm birth, pre-eclampsia, placental abruption, and impaired fetal neurological development — because the fetus relies entirely on maternal thyroid hormone during the first trimester before its own thyroid becomes functional. For obstetric or perinatal nursing assignments, the clinical recommendation to screen for thyroid dysfunction in early pregnancy — particularly in women with risk factors such as prior thyroid disease, type 1 diabetes, or family history — is directly relevant.

Hypothyroidism is most common in adults over 60, yet it is also most frequently missed in this population. The classic symptoms — fatigue, cold intolerance, constipation, cognitive slowing, weight gain — are easily attributed to normal ageing, depression, or comorbid conditions. Some older adults with hypothyroidism present with what appears to be exacerbation of heart failure, new-onset atrial fibrillation, or unexplained cognitive decline or dementia. Others are essentially asymptomatic and detected only through routine blood testing. The implication for gerontological nursing and care of the elderly assignments is that clinical suspicion needs to be maintained — and that thyroid function testing should be part of routine evaluation when older patients present with the non-specific complaints that hypothyroidism typically produces.

Acquired hypothyroidism in children — most commonly from Hashimoto’s thyroiditis — produces a clinical picture that differs meaningfully from adult presentation. The most characteristic feature is growth deceleration: children’s linear growth rate slows, resulting in falling height percentiles on growth charts, and bone age may be delayed relative to chronological age on X-ray. Paradoxically, some children with hypothyroidism appear to gain weight without a dramatic increase in height — producing a stocky, short phenotype. Academic performance may decline, and in adolescents, puberty may be delayed or occasionally precocious (the Van Wyk-Grumbach syndrome, in which severe hypothyroidism causes precocious puberty via cross-reactivity of elevated TSH with FSH receptors). For paediatric nursing assignments, growth monitoring and developmental surveillance are the clinical hooks that make hypothyroidism detection in children different from adult detection.